PVLA - Pieris Corp Bozor qiymati
Asosiy baholash vositasi bo'lib xizmat qiluvchi ushbu Pieris Pharmaceuticals (PVLA) narxlar grafigi onkologiyaga qarshi kurashish uchun antikalinlar ishlab chiqayotgan kompaniyaning dinamikasini namoyish etadi. Biznes logistik uzilishlar va sanksiyalarga nisbatan zaifdir, bu esa 2.43 ko'rsatkichiga ta'sir qiladi. Shu bilan birga, rahbariyat yangi sheriklik aloqalarini izlamoqda, ammo B2B aloqalarining buzilishi va kapital chiqib ketishi firmaning omon qolishini faqatgina FDA tasdiqlashlariga bog'lab qo'ymoqda.
Pieris Corp (PVLA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi statistikasi:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning kapitalga nisbati Pieris Pharmaceuticals|PVLA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Pieris Pharmaceuticals|PVLA - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Pieris Corp|PVLA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Pieris Pharmaceuticals|Tezkor likvidlik koeffitsiyenti pieris.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
PVLA - Sof foyda|Kelajakdagi foyda Pieris Pharmaceuticals|PVLA - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Pieris Pharmaceuticals Inc|PVLA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Pieris Corp|PVLA - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Pieris Pharmaceuticals|PVLA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi pieris.com|PVLA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Pieris Pharmaceuticals
Kompaniyaning fundamental tahlili:PVLA (Pieris Pharmaceuticals, Inc.)
Barcha muomala qismidagi aksiyalarning umumiy real vaqtdagi qiymatini ifodalovchi bozor kapitalizatsiyasi Pieris Pharmaceuticals (PVLA) kompaniyasining uzoq muddatli xatarlarini baholash uchun juda muhimdir. Kompaniyaning bozor kapitalizatsiyasini tahlil qilish orqali investor biznesning bozor qiymatini aniqlashi mumkin, bu hozirda avtomatlashtirilgan oqsil skrining tizimlarining joriy etilishi va ma'lumotlarni yig'ishni robotlashtirish bilan ta'minlanmoqda, bu esa texnologik kengayishning moliyaviy salohiyatini belgilaydi.
Muhim raqobatchilar
argenx - Bozor bahosi|BioNTech Inc. - Bozor qiymati|ABVX - Bozor qiymati|ADMA: Bozor qiymati|PTGX: Bozor kapitallashuvi|immunovant.com (IMVT) - Bozor kapitallashuvi|Bozor qiymati Kiniksa|Grifols SA - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Corp) - Bozor qiymati|Bozor kapitallashuvi AUPH (Aurinia Pharmaceuticals)|Bozor kapitallashuvi biocryst.com BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Bozor qiymati|Bozor bahosi AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi precigen.com|Bozor bahosi PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Bozor qiymati|Bozor kapitallashuvi UPB (Upstream Bio Corp)|Bozor kapitallashuvi Zenas Corp (ZBIO)|IMNM - Bozor qiymati|gossamerbio.com (GOSS) - Bozor bahosi|KalVista Pharmaceuticals, Inc. (KALV) - Bozor qiymati|Bozor bahosi Septerna, Inc.|Bozor bahosi SVRA|Bozor kapitallashuvi Rigel Corp|Bozor qiymati AnaptysBio, Inc. (ANAB)|astriatx.com - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (enGene)|rapt.com (RAPT) - Bozor qiymati|JBIO - Bozor qiymati|Bozor bahosi ACRS|KYTX: Bozor kapitallashuvi|TLSA - Bozor kapitallashuvi|CABA (Cabaletta Bio) - Bozor kapitallashuvi|Bozor qiymati Ventyx Biosciences Inc. VTYX|Bozor qiymati Theratechnologies Inc (THTX)|AVTX (Avalo Therapeutics Inc) - Bozor qiymati|Bozor kapitallashuvi ELDN (Eledon Pharmaceuticals)|Bozor kapitallashuvi agenusbio.com (AGEN)|CLYM - Bozor qiymati|Bozor kapitallashuvi zurabio.com ZURA|ATYR (aTyr) - Bozor bahosi|Adagene Inc. - Bozor qiymati|Bozor qiymati ImageneBio|Shattuck Therapeutics - Bozor bahosi|Bozor kapitallashuvi EQ|CNTB (connectbiopharm.com) - Bozor qiymati|Bozor kapitallashuvi IMUX (Immunic)|Bozor kapitallashuvi Atara Biotherapeutics, Inc. ATRA|IFRX - Bozor qiymati|Bozor qiymati XFOR (x4pharma.com)|adicetbio.com (ACET) - Bozor qiymati|Bozor bahosi Celularity|INMB (INmune Bio Corp) - Bozor kapitallashuvi|Bozor kapitallashuvi Barinthus Biotherapeutics Corp|Bozor kapitallashuvi KZR|Bozor bahosi sabbiotherapeutics.com SABS|Bozor kapitallashuvi AKTX (Akari Therapeutics Plc)|Enlivex Therapeutics Ltd (ENLV) - Bozor qiymati|QTTB: Bozor bahosi|GOVX - Bozor kapitallashuvi|EDSA (Edesa Biotech, Inc.) - Bozor bahosi|IBIO: Bozor qiymati|CARM (Carisma Therapeutics Inc) - Bozor kapitallashuvi|XTL Biopharmaceuticals Ltd (XTLB) - Bozor kapitallashuvi|Bozor kapitallashuvi BOLT|Bozor bahosi hcwbiologics.com HCWB|Bozor kapitallashuvi APVO (Aptevo Therapeutics Inc.)|Bozor kapitallashuvi aimimmuno.com AIM|ADTX - Bozor qiymati|GRI: Bozor qiymati|XORTX (XRTX) - Bozor qiymati|HIND - Bozor kapitallashuvi|Bozor qiymati Revelation Biosciences|indaptusrx.com - Bozor bahosi|Bozor bahosi SCNI (Scinai Immunotherapeutics Ltd.)|Bozor qiymati CALI (calcimedica.com)|Bozor qiymati Affimed N.V. AFMD|Allakos Inc - Bozor qiymati|HOOKIPA - Bozor kapitallashuvi|IGMS - Bozor kapitallashuvi|iTeos Therapeutics, Inc. (ITOS) - Bozor qiymati|Bozor bahosi OCEA (Ocean Biomedical Inc)|TCBP (TC BioPharm (Holdings) PLC) - Bozor kapitallashuvi|THRD: Bozor qiymati
